Skip to main content
. 2026 Feb 19;11:100677. doi: 10.1016/j.esmorw.2025.100677

Table 2.

Proportion of patients with worsening assessment scores at week 12

Abiraterone n = 28
n (%)
Enzalutamide n = 28
n (%)
P value
BOMC 8 (29) 11 (39) 0.57
GDS 8 (29) 13 (46) 0.27
FRQ 14 (50) 15 (54) >0.99

BOMC, Blessed Orientation-Memory-Concentration; GDS, Geriatric Depression Scale; FRQ, Falls Risk Questionnaire.